The effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on pregnancy outcomes in assisted reproductive cycles
Phase 2
Recruiting
- Conditions
- Infertility.
- Registration Number
- IRCT20160703028756N7
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Hip women under the age of 40 who have undergone IVF / ICSI treatment protocols are endocrine candidates for grade A or B embryos.
Exclusion Criteria
Azoospermia through sperm testing
History of uterine surgery through history
Severe endometriosis through history and ultrasound findings
Hydrosalpinx by ultrasound or hysterosalpingography
Endocrine disorders such as diabetes thyroid via blood biochemistry test
History of operative hysteroscopy
History of recurrent miscarriages
More repeated failures equal to 3 times in the history
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Follicle size. Timepoint: During embryo transfer and one week after embryo transfer. Method of measurement: sonography.;Type of embryo transferred. Timepoint: ---. Method of measurement: --.;Number of embryos transferred per cycle. Timepoint: Patient cycle. Method of measurement: Laboratory.;AMH. Timepoint: Before embryo transfer. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method Ongoing pregnancy. Timepoint: After embryo transfer. Method of measurement: Question from the patient.;Cilinical pregnancy. Timepoint: After embryo transfer. Method of measurement: Question from the patient.;Chemical pregnancy. Timepoint: After embryo transfer. Method of measurement: Question from the patient.